Quarterly report · Q3
3583.TEDINET S100Q49V
Period2022-04-01 → 2022-12-31
Filed2023-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.0bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥5.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.1bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥507m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥558m | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥519m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥727m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥563m | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥561m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥563m | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥365m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥537m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥395m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥365m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥395m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥9.5bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥9.4bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥9.3bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.8bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.7bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥5.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.2bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥131.72 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.34 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥194.04 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥142.8 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.61 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 60.3% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.2% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥18m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥344,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥18m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | −¥6m |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3m |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥73m |
| jpcrp040300-q3r_E00584-000Technological Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥2.9bn |
| jpcrp040300-q3r_E00584-000Technological Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥2.9bn |
| jpcrp040300-q3r_E00584-000Technological Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥669m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥741m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥21m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥735m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-12-31 | ¥8m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥6m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-12-31 | −¥17m |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥1.0bn |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥1.0bn |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥3m |
| jpcrp040300-q3r_E00584-000Medical Productsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥112m |
| jpcrp040300-q3r_E00584-000Technological Productsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E00584-000Technological Productsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥3.0bn |
| jpcrp040300-q3r_E00584-000Technological Productsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥689m |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥4.1bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥4.1bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥3m |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥801m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥4.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥4.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥784m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 378
| Item | Context | Value | Unit |
|---|---|---|---|
| Non operating income | Prior1YTDDuration | 20512000 | JPY |
| Non operating income | CurrentYTDDuration | 25734000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 11214000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 10045000 | JPY |
| Other noe | Prior1YTDDuration | 4826000 | JPY |
| Other noe | CurrentYTDDuration | 2806000 | JPY |
| Non operating expenses | Prior1YTDDuration | 16040000 | JPY |
| Non operating expenses | CurrentYTDDuration | 12851000 | JPY |
| Ordinary income | Prior1YTDDuration | 562620000 | JPY |
| Ordinary income | CurrentYTDDuration | 519428000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 2303000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 64878000 | JPY |
| Extraordinary income | Prior1YTDDuration | 2303000 | JPY |
| Extraordinary income | CurrentYTDDuration | 64878000 | JPY |
| Loss on sales of noncurrent assets el | Prior1YTDDuration | - | JPY |
| Loss on sales of noncurrent assets el | CurrentYTDDuration | 22869000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 2293000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 122000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 2293000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 22992000 | JPY |
| Income before income taxes | Prior1YTDDuration | 562630000 | JPY |
| Income before income taxes | CurrentYTDDuration | 561314000 | JPY |
| Income taxes current | Prior1YTDDuration | 160159000 | JPY |
| Income taxes current | CurrentYTDDuration | 108053000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 7738000 | JPY |
| Income taxes deferred | CurrentYTDDuration | 88057000 | JPY |
| Income taxes | Prior1YTDDuration | 167898000 | JPY |
| Income taxes | CurrentYTDDuration | 196110000 | JPY |
| Profit loss | Prior1YTDDuration | 394732000 | JPY |
| Profit loss | CurrentYTDDuration | 365204000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 394732000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 365204000 | JPY |
| Profit loss | Prior1YTDDuration | 394732000 | JPY |
| Profit loss | CurrentYTDDuration | 365204000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 1861000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 7581000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 17990000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | -7551000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 19851000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 29000 | JPY |
| Comprehensive income | Prior1YTDDuration | 414584000 | JPY |
| Comprehensive income | CurrentYTDDuration | 365234000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 414584000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 365234000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember | 3031369000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember | 1042595000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 4073964000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1626000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 4075590000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember | - | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |